Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariaelena Capone

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Scientific Reports|April 1, 2022
Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patientsMaria Luigia Carbone, Gabriele Madonna, Alessia Capone, et al.
Journal of Translational Medicine|August 31, 2013
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanomaMaria Colombino, Amelia Lissia, Mariaelena Capone, et al.
Oncoimmunology|December 8, 2018
PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumabGabriele Madonna, Carmen Ballesteros-Merino, Zipei Feng, et al.
Journal of Translational Medicine|May 11, 2023
Potential clinical implications of CD4<sup>+</sup>CD26<sup>high</sup> T cells for nivolumab treated melanoma patientsDomenico Galati, Serena Zanotta, Mariaelena Capone, et al.
Frontiers in Immunology|August 26, 2022
PD-L1<sup>+</sup> neutrophils as novel biomarkers for stage IV melanoma patients treated with nivolumabLeonardo Cristinziano, Luca Modestino, Mariaelena Capone, et al.
The Oncologist|November 16, 2023
Development of a Prognostic Model for Early Breast Cancer Integrating Neutrophil to Lymphocyte Ratio and Clinical-Pathological CharacteristicsSara Socorro Faria, Diana Giannarelli, Vladmir Claudio Cordeiro de Lima, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 11, 2025
Metabolomic signatures in liquid biopsy are associated with overall survival in metastatic melanoma patients treated with immune checkpoint inhibitor therapySusan Costantini, Gabriele Madonna, Mariaelena Capone, et al.
International Journal of Molecular Sciences|March 11, 2023
New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with CancerSusan Costantini, Gabriele Madonna, Elena Di Gennaro, et al.
Cancer Letters|December 3, 2014
Ran signaling in melanoma: implications for the development of alternative therapeutic strategiesEmilia Caputo, Ena Wang, Anna Valentino, et al.
Cancers|June 2, 2021
The Ratio of GrzB<sup>+</sup> - FoxP3<sup>+</sup> over CD3<sup>+</sup> T Cells as a Potential Predictor of Response to Nivolumab in Patients with Metastatic MelanomaGiosuè Scognamiglio, Mariaelena Capone, Francesco Sabbatino, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Scientific Reports|April 1, 2022
Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patientsMaria Luigia Carbone, Gabriele Madonna, Alessia Capone, et al.
Journal of Translational Medicine|August 31, 2013
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanomaMaria Colombino, Amelia Lissia, Mariaelena Capone, et al.
Oncoimmunology|December 8, 2018
PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumabGabriele Madonna, Carmen Ballesteros-Merino, Zipei Feng, et al.
Journal of Translational Medicine|May 11, 2023
Potential clinical implications of CD4<sup>+</sup>CD26<sup>high</sup> T cells for nivolumab treated melanoma patientsDomenico Galati, Serena Zanotta, Mariaelena Capone, et al.
Frontiers in Immunology|August 26, 2022
PD-L1<sup>+</sup> neutrophils as novel biomarkers for stage IV melanoma patients treated with nivolumabLeonardo Cristinziano, Luca Modestino, Mariaelena Capone, et al.
The Oncologist|November 16, 2023
Development of a Prognostic Model for Early Breast Cancer Integrating Neutrophil to Lymphocyte Ratio and Clinical-Pathological CharacteristicsSara Socorro Faria, Diana Giannarelli, Vladmir Claudio Cordeiro de Lima, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 11, 2025
Metabolomic signatures in liquid biopsy are associated with overall survival in metastatic melanoma patients treated with immune checkpoint inhibitor therapySusan Costantini, Gabriele Madonna, Mariaelena Capone, et al.
International Journal of Molecular Sciences|March 11, 2023
New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with CancerSusan Costantini, Gabriele Madonna, Elena Di Gennaro, et al.
Cancer Letters|December 3, 2014
Ran signaling in melanoma: implications for the development of alternative therapeutic strategiesEmilia Caputo, Ena Wang, Anna Valentino, et al.
Cancers|June 2, 2021
The Ratio of GrzB<sup>+</sup> - FoxP3<sup>+</sup> over CD3<sup>+</sup> T Cells as a Potential Predictor of Response to Nivolumab in Patients with Metastatic MelanomaGiosuè Scognamiglio, Mariaelena Capone, Francesco Sabbatino, et al.
Pageof 7